A cross-sectional study has been performed to investigate the clinical value of Chi3l1 in patients with PM/DM, which suggests that the serum Chi3l1 level is a possible useful biomarker for PM/DM diagnosis [272]. This evidence concerns the gene CHI3L1 and polymyositis.